Jun Wang

1PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 06, 2022
Discovery of mobocertinib, a new irreversible tyrosine kinase inhibitor indicated for the treatment of non-small-cell lung cancer harboring EGFR exon 20 insertion mutations.

Jun Wang, Daniel Lam, Jeffrey Yang

Pageof 1

Frequent Collaborators

1 joint publications

Daniel Lam

1 joint publications

Jeffrey Yang

1 joint publications

Longqin Hu